USPTO Biotech and Pharma Pendency and Projections

At the USPTO's Biotechnology and Pharmaceutical Customer Partnership Meeting on November 10, 2005, Commissioner for Patents John Doll presented the following information on patent application pendancy as of October 1, 2005:

And here are the USPTO's pendency projections under various scenarios: